Turning Pennies into dollars: (Nasdaq: DNDN), (OTCBB: FSRT), (OTCBB: UDTT), (OTCBB: XSNX).
Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559
For more info: http://dndn.realpennies.com
Dendreon Corporation (Nasdaq: DNDN ) (April 4, 2008) announced that it has entered into a definitive agreement with an institutional investor to sell 8.0 million shares of its common stock and warrants to purchase up to 8.0 million shares of its common stock for gross proceeds of approximately $47 million, before deducting placement agent fees and estimated offering expenses, in a "registered direct" offering. The investor has agreed to purchase the shares of common stock and warrants to purchase common stock at a negotiated purchase price of $5.92 per share and a warrant exercise price of $20.00 per share. For the common stock purchased, this represents a 17% premium to the closing bid price of the common stock on April 2, 2008. The warrants will be exercisable at any time on or after October 8, 2008 and prior to the seventh anniversary of the closing of the transaction. The closing bid price of the common stock on the Nasdaq Global Market on April 2, 2008 was $5.06 per share. Lazard Capital Markets LLC served as sole placement agent for the offering.
The securities described above are being offered by Dendreon pursuant to registration statements previously filed and declared effective by the Securities and Exchange Commission (the "SEC"). The transaction is expected to close on or about April 8, 2008, subject to customary closing conditions. We intend to use the net proceeds from the sale of the shares to fund our commercialization activities for Provenge (sipuleucel-T), including the investment in specialized technology systems; to fund clinical trials for PROVENGE and our other product candidates; to fund our other research and preclinical development activities for our active immunotherapies and small molecule products; to satisfy third party obligations; and for other general corporate purposes, including working capital. We also may use a portion of the net proceeds to acquire complementary technologies or products, although we currently have no agreements or commitments in this regard.
For more info: http://fsrt.realpennies.com
FreeStar Technology Corp. (OTCBB: FSRT ) (April 4, 2008) an international card payments processor and technology company, today announced that its Rahaxi Processing Oy. subsidiary will immediately commence sales of Hypercom's (NYSE: HYC) PCI-approved, mobile credit/debit terminal in Finland. The action follows Finnish EMV Level 1 & 2 Chip and Pin certification of the palm-sized, 32-bit wireless signature capture device.
"The demand for EMV-certified payment products is escalating sharply in Finland; we have achieved that security standard with the M4100 Blade, and we intend to quickly introduce this innovative and truly mobile payment device to our merchant base," said Dr. Jose Enrique Perez, Managing Director, Rahaxi Processing Oy.
Weighing in at just over 200g and measuring 12.67cm (4.9 inches) long, 6.93cm (2.7 inches wide), and 2.92cm (1.15 inches) deep, the M4100 Blade is a fraction of the size of competitive models, is battery operated, and requires no external battery or modem.
These features eliminate size and weight problems that make other wireless units impractical for use in mobile scenarios. The M4100 Blade is also a rugged terminal that incorporates a top-of-the-line high-contrast color touch screen, accepts magnetic stripe and smart cards, and offers a contactless reader, clip-on printer and docking station.
"This marks yet another achievement in our continued success with EMV-certified payment options. Rahaxi continues to be on the forefront of this technology with successful certification in partnership with Hypercom products," said Paul Egan, CEO of Rahaxi parent company FreeStar Technologies. He added, "This certification allows us to continue to expand our offerings to our core merchant base and allows us to expand that base greatly."
For more info: http://dndn.realpennies.com
Universal Detection Technology (OTCBB: UDTT ) (April4, 2008), a developer of early-warning monitoring technologies to protect people from bioterrorism and a provider of counter terrorism training and solutions, announced that it presented its bacterial spore detection technology portfolio to the U.S. Army Edgewood Chemical Biological Center (ECBC) Biosensor Team. The purpose of the meeting was for UDTT and the Army Biosensor Team to evaluate potential collaboration and funding opportunities.
ECBC develops and tests systems to enhance the ability of military personnel and civilian emergency responders to detect and identify chemical/biological warfare agents and contaminants. Development efforts are constantly improving and refining these capabilities. ECBC activities span the life cycle of chemical and biological defense research and product development.
"This is our second meeting at the U.S Army ECBC in this year," said Mr. Amir Ettehadieh, UDTT Director of Research and Development. "We look forward to working with the Biosensor Team to customize our proprietary bacterial spore detection technology to the Army's Biodetection needs," he added.
UDTT's BSM-2000 combines a bioaerosol capture device with a simple and robust chemical test for bacterial spores that is completely automated. We propose to use the BSM-2000 as a front-end monitor to the Biohazard Detection System (BDS) or any other Secondary monitor with the promise of drastically reducing the recurring operating costs for anthrax screening at postal facilities and any other facility where bio-terrorism is of concern.
For more info: http://xsnx.realpennies.com
XsunX, Inc. (OTCBB: XSNX) (April 4, 2008) a solar technology Company engaged in the build- out of its multi-megawatt thin film photovoltaic (TFPV) solar manufacturing facilities, announced that it had completed negotiations and entered into a lease for its new manufacturing facility to be located in Oregon, U.S.A.
The existing building, located in the City of Wood Village just east of Portland, Oregon, provides approximately 90,000 square feet for the Company's integrated TFPV manufacturing operations. The location provides strategic access to shipping and transportation corridors, and sufficient amounts of clean hydro electric power to operate the Company's manufacturing systems.
"We are happy to announce that we have selected a building, entered into a lease, and that we can begin efforts to prepare that facility for our manufacturing systems," stated Mr. Tom Djokovich, CEO for XsunX. "We conducted a design review of the facility and its suitability for our planned manufacturing system and were pleased with the results.
Had we built a facility from scratch, it would have been less of a challenge to design floor space specifically to meet our needs; however, in the end we believe it was the correct choice to work with existing buildings in an effort to reduce start-up and operating costs.
Overall, our timeline was to complete the lease process near the end of March and we are still on track with our efforts to establish our first 25 mega-watts of thin-film solar module manufacturing capabilities," concluded Djokovich.
The building XsunX is leasing in Oregon was operated until recently by another high tech manufacturer from whom XsunX will be subleasing the facilities. In its design and use study of the building, XsunX found certain existing support systems of the structure complementary to its operations and is negotiating with the current operator to purchase certain industrial equipment for use by XsunX in its manufacturing operations. XsunX and the current operator have worked with the primary landlord during the negotiation process as the master lease provides for sublease approval by the primary landlord. This approval is anticipated within fifteen days.
Read our full disclaimer at: http://www.realpennies.com/start.html
Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on RealPennies. For more movers: http://www.realpennies.com/wrapup.html
Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice.
Sitemap: http://www.realpennies.com/sitemap.html
Sponsored by: http://www.isthemarketopen.com
RealPennies .
Telephone: 1-800-940-6559
Matt /at/ realpennies.com
No comments:
Post a Comment